Astellas Pharma Inc - Company Profile
Powered by
All the data and insights you need on Astellas Pharma Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Astellas Pharma Inc Strategy Report
- Understand Astellas Pharma Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Astellas Pharma Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
WO2022192622A1 | Application | COMPOSITIONS AND METHODS FOR TREATING X-LINKED MYOTUBULAR MYOPATHY | September 15, 2022 | |
EP3906088A4 | Search Report | LEISTUNGSSTEUERUNGEN FÜR EINE MIT ULTRASCHALLWELLEN ANGETRIEBENE IMPLANTIERBARE VORRICHTUNG | A61B2560/0219; A61B5/002; A61B5/0028; A61B5/0031; A61B5/01; A61B5/021; A61B5/024; A61B5/14532; A61B5/14539; A61B5/14556; A61B5/24; A61B5/4035; A61B5/4047; A61B5/4052; A61B5/686; A61N1/08; A61N1/36053; A61N1/36128; A61N1/37211; A61N1/37276; A61N1/3787; H02J50/15; H02J50/80; H02J7/0049; H02J7/00711 | September 14, 2022 |
CN110167926B | Grant | 聚-ADP核糖聚合酶(PARP)抑制剂 | A61K31/517; A61K31/519; A61P13/12; A61P21/00; A61P25/00; A61P3/00; A61P35/00; A61P9/00; C07D239/74; C07D401/06; C07D401/08; C07D401/14; C07D403/06; C07D403/08; C07D403/14; C07D405/10; C07D405/14; C07D417/08; C07D417/14; C07D471/04; C07D487/04; C07D495/04 | September 13, 2022 |
AU2022218516A1 | Application | Improved assays for potency of human retinal pigment epithelium (RPE) cells and photoreceptor progenitors | G01N15/14; G01N21/6486; G01N2800/164; G01N33/5005; G01N33/582; G01N33/84 | September 08, 2022 |
US20220280572A1 | Application | METHODS OF TREATING VASCULAR DISEASES | A61K35/28; A61K35/44; A61P9/12; C12N5/0647; C12N5/069 | September 08, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer